Stepwise PIPs: A Solution for the Challenges of Pediatric Drug Development
Early paediatric investigation plan (PIP) submissions – an unnecessarily bitter medicine? In the European Union…
Jim Gallagher2023 年 4 月 14 日
Why Performing Key CMC Activities Early Can Aid De-risking Your Drug Development Program
This white paper focuses on best practices for developing a CMC strategy for orally administered…
Jim Gallagher2023 年 4 月 13 日
Repurposing Data & Advanced Analytics to Validate Surrogate Endpoints
可以使用再利用的数据和高级分析来验证替代终点。A surrogate…
Jim Gallagher2023 年 4 月 13 日
Tips & Tricks for Optimizing Your Pharmacokinetic Modeling & Simulation
学习如何通过专家技巧简化您的 PK/PD 工作流程。
Jim Gallagher2023 年 3 月 23 日
Leveraging AI to Accelerate Drug Discovery: Vyasa Joins Certara
Applying Vyasa’s deep learning expertise to Certara products will enable our clients to expand how…
Jim Gallagher2023 年 3 月 10 日
Advancing data discovery in the life sciences through artificial intelligence
Vyasa has developed deep-learning artificial intelligence solutions for organizations looking to solve the complex data…
Jim Gallagher2023 年 3 月 2 日
Certara Announces Transition Plan For Chief Financial Officer
PRINCETON, N.J. – 2023 年 3 月 1 日 – Certara, Inc. （纳斯达克股票代码：CERT), announced today that John…
Jim Gallagher2023 年 3 月 1 日
